Did you know...

In 2013 1,003,703 assistive devices were distributed including 795,835 spectacles; 28,918 low vision devices, 21,427 hearing aids, 115,691 orthopaedic appliances and 41,832 other devices.
Read more facts and figures here

CBM in numbers

This image shows a young Ugandan boy with bowlegs standing with his elder sister and his nephew, at the entrance of a hospital. They are all wearing colourful African clothes and smiling
Denis (red shirt) with his half-sister Roy and his nephew Fred, on the day of his surgery at the entrance of CoRSU, a CBM partner in Uganda. Denis has been treated successfully for severe bowlegs.

In its mission to improve the quality of life of persons with disabilities in the world's poorest communities, CBM, with partners, reached more than 14 million people in 2014. They came from all walks of life and from many different cultures - CBM offers help irrespective of religion and actively promotes inclusion of women and girls.

A global operation

Together with the support from over 900,000 active supporters / donors through 11 Member Associations, CBM and its 483 partner organisations supported 672 projects in 65 countries in Africa, Asia, Latin America and the Middle East in 2014, with a programme expenditure of EUR 63.8 million, reaching more than 14.1 million people.

A further 18.3 Million patients were treated for blinding onchocerciasis and trachoma and 12.9 million treatments for non-blinding, disabling, neglected tropical diseases were provided. 

Quality of work

CBM continued to implement its strategy to focus its work in fewer countries (from 99 in 2009 to 65 in 2014), and with fewer partners  (from 732 in 2009 to 483 in 2014). The reduction in countries and partners is to ensure consistent focus in our core areas of activity and ongoing development of the quality of our work.

Empowerment driving inclusion

Empowerment is a key driver to achieve inclusion of persons with disabilities as equal members of their communities. CBM continued to emphasise and develop work in:
  • Community Based Rehabilitation (CBR) projects (207 in 2014) as well as facilitating peer groups for persons with disabilities and their families with 209,759 participants,
  • Education and Rehabilitation projects (388 in 2014) reaching 774,320 persons,
  • Livelihood projects (102 in 2014) reaching 130,554 persons,
  • Advocacy to influence local or national policy on disability (441 projects were involved in advocacy work); and 488 projects were involved at the community level to create awareness about the rights of persons with disabilities.

2014 Key Statistics

1) In 2014 a total of 14,193,489 beneficiaries (2013: 10.5 Mio) received services from CBM's partners of which:
  • 11,949,029 (2013: 8.4 Mio) people received medical eye services
  •  796,874 (2013: 702,885) people received medical services for ear conditions
  •  673,266 (2013: 665,937) people received medical services for orthopaedic conditions
  •  774,320 (2013: 801,785) clients received education or rehabilitation services
  • 991,203 operations (2013: 848,885) were performed including 905,776 (2013: 794,061) eye operations inclusive 600,562 cataract operations (2013: 563,432), 15,531 (2013: 18,212) ear operations, and 69,645 (2013: 36,441) orthopaedic operations.
  • 916,899 assistive devices (2013: 1,003,703) were distributed including 705,177 spectacles (2013: 795,835); 35,114 low vision devices (2013: 28,918); 19,968 hearing aids (2013: 21,427); 128,539 orthopaedic appliances (2013: 115,691); and 28,101 other devices (2013: 41,832).
  • More than 55,000 professionals were trained in 2014 (2013: 74,000) (in particular 2,181 doctors, 3,804 nurses and 12,716 teachers) to enable our partners and enhance local and national capacity.

2) Mass Drug Administration (MDA)/ Neglected Tropical Diseases eye health related:
  • Of the 18,309,986 persons (2013: 13.8 Mio) receiving treatment in 2014,
  •  16,675,731 people (2013: 11.9 Mio) were treated with Mectizan for onchocerciasis (oncho);
  •  1,634,255 people (2013: 1.8 Mio) were treated with Azithromycin for trachoma
3) Comprehensive Mass Drug Administration (MDA) activities (non-eye):
Of the 12,915,526 treatments (2013: 6.3 Mio) for non-eye related MDA activities,
  • 10,124,631 treatments (2013: 5.7 Mio) were provided for Lymphatic Filariasis (LF) where co-endemic with Onchocerciasis or where Government policies require an integrated approach (e.g. Nigeria, Burundi).
  • 1,404,023 (2013: 629,032) for Soil transmitted helminthes (STH) and
  • 1,386,872 (2013: 9,455) for Schistosomiasis (SCH)) where we have an integrated NTD programme or where Government policies require an integrated approach (e.g. Nigeria, Burundi).


Go to Website

CBM worldwide

back to CBM international

Or try this:

Due to your location and language settings you might be interested in the following CBM sites:

© CBM e.v.

Meta navigation, Legal

Access key details